Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Total Current Liabilities (2018 - 2023)

Avai Bio's Total Current Liabilities history spans 5 years, with the latest figure at $1.7 million for Q4 2023.

  • For Q4 2023, Total Current Liabilities rose 105.26% year-over-year to $1.7 million; the TTM value through Dec 2023 reached $1.7 million, up 105.26%, while the annual FY2023 figure was $874719.0, N/A changed from the prior year.
  • Total Current Liabilities for Q4 2023 was $1.7 million at Avai Bio, up from $1.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.7 million in Q4 2023 and bottomed at $30523.0 in Q1 2019.
  • The 4-year median for Total Current Liabilities is $828849.0 (2022), against an average of $837966.2.
  • The largest annual shift saw Total Current Liabilities skyrocketed 1399.38% in 2020 before it soared 53.01% in 2023.
  • A 4-year view of Total Current Liabilities shows it stood at $298915.0 in 2019, then skyrocketed by 223.96% to $968356.0 in 2020, then dropped by 14.87% to $824372.0 in 2022, then surged by 105.26% to $1.7 million in 2023.
  • Per Business Quant, the three most recent readings for AVAI's Total Current Liabilities are $1.7 million (Q4 2023), $1.3 million (Q3 2023), and $1.3 million (Q2 2023).